Clinical Trials Logo

Clinical Trial Summary

The project is designed as a randomized controlled, double-blinded, cross-over trial, including 10 healthy postmenopausal women consuming fermented red clover extract or placebo twice daily over a two-week period. After the first trial (two weeks), participants will undergo a two-week washout period, after which they will receive the opposite trial drink for two weeks. The trial period runs over six weeks. Before each of the two trial rounds, participants will meet in the laboratory and perform muscle strength tests (trial days 1 and 3). After each trial round (trial days 2 and 4), participants will meet fasting in the laboratory, and a blood test and a muscle biopsy will be taken initially. Next, the subject consumes the test drink (placebo or red clover extract) before the subject performs a strength training session with one leg. Right after the training session, the subject consumes a protein drink. Three hours after the protein drink, another muscle biopsy is taken. During the period from the protein drink to the final biopsy, the subject performs two muscle strength tests (respectively grip strength and maximum upper arm muscle strength (biceps)). The primary target parameter is muscle protein signaling measured in the muscle tissue samples using the western blotting method.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04154306
Study type Interventional
Source University of Aarhus
Contact
Status Completed
Phase N/A
Start date November 1, 2019
Completion date November 1, 2020

See also
  Status Clinical Trial Phase
Terminated NCT03631680 - The Role of Estrogen in Adipocyte Remodeling Following Surgical Menopause
Not yet recruiting NCT04513405 - Estrogens Levels and Receptors Status and Skin Tears N/A
Active, not recruiting NCT05057546 - Ovarian Hormone Regulation of Central and Cerebrovascular Hemodynamics (NoMEN Study) Phase 4
Not yet recruiting NCT06343870 - Estradiol and Testosterone Subdermal Implants for Menopause Treatment (ESTIME) Phase 3
Recruiting NCT06264882 - Cardiometabolic Consequences of the Loss of Ovarian Function Phase 4
Not yet recruiting NCT04245527 - Use of Infrared Photomodulation for Hormonal Balance (Joovvin' for Hormonal Health) N/A
Completed NCT00572858 - Estrogen Deficiency and Cardiovascular Disease in Premenopausal Women
Recruiting NCT04419727 - Estrogen Receptors and Peripheral Artery Disease
Completed NCT03018366 - Atherosclerosis, Immune Mediated Inflammation and Hypoestrogenemia in Young Women Phase 2
Completed NCT03112226 - Effects of Ovarian Hormone Suppression on Vascular and Cognitive Function N/A
Recruiting NCT05587920 - Effect of Oestrogen on Musculoskeletal Outcomes
Withdrawn NCT03856268 - Understanding the Roles of Hormones in Adipocyte Remodeling Following Menopause